HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2217127Generated: November 3, 2026
1-(2-Hydroxyethyl)piperazine → HCID 135413559, compound
https://huagongshe.com/reaction/2217127
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1-(2-Hydroxyethyl)piperazine | HCID 7677 | — |
| Reactant | 1,1'-Carbonyldiimidazole | HCID 68263 | — |
| Reactant | HCID 135829584 | HCID 135829584 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 135413559 | HCID 135413559 | — |
Reaction Steps
1,1′-Carbonyldiimidazole (20 mg, 0.19 mmol) was added to a solution of 5-(4-(aminomethyl)-3-methylbenzoyl)-1-methyl-4,10-dihydropyrazolo-[5,4-b][1,5]benzodiazepine (31 mg, 0.09 mmol) in DMF (3 ml). The solution was stirred at room temperature for 1 h, a solution of 1-(2-hydroxyethyl)-piperazine (13 mg, 0.10 mmol) in DMF (2 ml) was added and stirring was continued for 72 h. The solution was concentrated in vacuo and the residue was partitioned between chloroform and brine. The organic layer was separated and concentrated in vacuo. The residue was purified by flash chromatography on silica gel (eluant 7% methanol/chloroform) to give a white solid identified as 5-(4-(4-(2-hydroxyethyl)piperazine-1-carbonylaminomethyl)-3-methylbenzoyl)-1-methyl-4,10-dihydropyrazolo[5,4-b][1,5](22 mg, 48%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07407949B2 |
|---|
| Source dataset | uspto-grants-2008_08 |
|---|
| ORD ID | ord-282b3df9de6a4979bb9f3050335d8543 |
|---|
| Source note | uspto-grants-2008_08 |
|---|